Higher 25-hydroxyvitamin D level is associated with increased risk for Behçet's disease. Issue 2 (February 2021)
- Record Type:
- Journal Article
- Title:
- Higher 25-hydroxyvitamin D level is associated with increased risk for Behçet's disease. Issue 2 (February 2021)
- Main Title:
- Higher 25-hydroxyvitamin D level is associated with increased risk for Behçet's disease
- Authors:
- Zhong, Zhenyu
Su, Guannan
Du, Liping
Zhou, Qingyun
Li, Fuzhen
Chi, Wei
Liu, Shengyun
Zhang, Meifen
Zuo, Xianbo
Yang, Peizeng - Abstract:
- Summary: Background & aim: Previous studies showed a vitamin D deficiency in patients with Behçet's disease, suggesting potential benefits of vitamin D supplementation in the prevention and treatment of Behçet's disease. Interpretation of these studies may be limited by reverse causality or confounding bias. We aim to determine the causal association between serum 25-hydroxyvitamin D [25(OH)D] and the risk of Behçet's disease by Mendelian randomization. Methods: An allele score formed by four variants (rs2282679, rs10741657, rs12785878 and rs6013897) that were associated with serum 25(OH)D level, was examined using data of genome-wide association study (GWAS) on 999 Behçet's disease and 4417 healthy individuals of Chinese ancestry and validated using data of GWAS on 1215 Behçet's disease and 1278 controls of Turkish ancestry. The primary outcome was the risk of Behçet's disease, evaluated by an inverse variance weighted average of the associations with genetically determined 25(OH)D levels. Results: The inverse variance weighted estimate showed that genetically increased 25(OH)D level was associated with a higher risk of Behçet's disease. In the Chinese cohort, the odds ratio for Behçet's disease in one standard deviation increase of natural log-transformed 25(OH)D level was 3.82 (95% CI: 1.27–11.42). Data from Turkish cohort confirmed the association with Behçet's disease (OR, 95% CI: 4.18, 1.15–15.12). In overall combination of Chinese and Turkish cohorts, the odds ratioSummary: Background & aim: Previous studies showed a vitamin D deficiency in patients with Behçet's disease, suggesting potential benefits of vitamin D supplementation in the prevention and treatment of Behçet's disease. Interpretation of these studies may be limited by reverse causality or confounding bias. We aim to determine the causal association between serum 25-hydroxyvitamin D [25(OH)D] and the risk of Behçet's disease by Mendelian randomization. Methods: An allele score formed by four variants (rs2282679, rs10741657, rs12785878 and rs6013897) that were associated with serum 25(OH)D level, was examined using data of genome-wide association study (GWAS) on 999 Behçet's disease and 4417 healthy individuals of Chinese ancestry and validated using data of GWAS on 1215 Behçet's disease and 1278 controls of Turkish ancestry. The primary outcome was the risk of Behçet's disease, evaluated by an inverse variance weighted average of the associations with genetically determined 25(OH)D levels. Results: The inverse variance weighted estimate showed that genetically increased 25(OH)D level was associated with a higher risk of Behçet's disease. In the Chinese cohort, the odds ratio for Behçet's disease in one standard deviation increase of natural log-transformed 25(OH)D level was 3.82 (95% CI: 1.27–11.42). Data from Turkish cohort confirmed the association with Behçet's disease (OR, 95% CI: 4.18, 1.15–15.12). In overall combination of Chinese and Turkish cohorts, the odds ratio for Behçet's disease per standard deviation increase of natural log-transformed 25(OH)D level was estimated to be 3.96 (95% CI: 1.72–9.13; P = 0.001). No significant evidence of pleiotropy and heterogeneity was detected. Conclusions: On the basis of evidence in 7909 human beings, this study provides the newest indication that a lifelong higher 25(OH)D level is associated with an increased risk of Behçet's disease. Special attention should be paid to the potential harm of long-term or high-dose use of vitamin D supplements in clinical practice. … (more)
- Is Part Of:
- Clinical nutrition. Volume 40:Issue 2(2021)
- Journal:
- Clinical nutrition
- Issue:
- Volume 40:Issue 2(2021)
- Issue Display:
- Volume 40, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 40
- Issue:
- 2
- Issue Sort Value:
- 2021-0040-0002-0000
- Page Start:
- 518
- Page End:
- 524
- Publication Date:
- 2021-02
- Subjects:
- Vitamin D -- 25-Hydroxyvitamin D -- Behçet's disease -- Mendelian randomization -- Inflammation
Critically ill -- Nutrition -- Periodicals
Diet therapy -- Periodicals
Parenteral feeding -- Periodicals
Enteral feeding -- Periodicals
Enteral Nutrition -- Periodicals
Parenteral Nutrition -- Periodicals
Metabolism -- Periodicals
Diétothérapie -- Périodiques
Alimentation parentérale -- Périodiques
Alimentation entérale -- Périodiques
Nutrition -- Périodiques
Diet therapy
Enteral feeding
Nutrition
Parenteral feeding
Electronic journals
Periodicals
Electronic journals
615.854 - Journal URLs:
- http://www.sciencedirect.com/science/journal/02615614 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.clnu.2020.05.049 ↗
- Languages:
- English
- ISSNs:
- 0261-5614
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.314500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 15583.xml